Navigation Links
New Genetic Test Helps Athletes Maximize Performance, Identify Undiagnosed Risk Factors
Date:4/27/2011

RICHMOND, Va., April 27, 2011 /PRNewswire/ -- It's a simple home genetic test, but the results it produces can make workouts more effective, children's sports choices more appropriate and trainers' awareness of potential risk factors more precise.  It can even save a life. American International Biotechnology Services (AIBioTech) today announced the launch of Sports X Factor, a test kit that provides athletes and parents of young sports competitors a wealth of information about their athletic strengths, potential health hazards and guidance for workout programs that are tailored to maximize performance.

The $200 test, which is available to the general public at www.SportsXFactor.com, enables individuals to understand how to maximize strength, power, and endurance.  Even more important, the test can identify the length of time an athlete needs to rest after experiencing a concussion, his or her chances for negative results including cardiac risk factors and various other hazards. Sports X Factor identifies increased risks of developing health conditions such as the kind of undiagnosed heart conditions that have felled young athletes during or immediately after strenuous workouts or competitions.  Various options available with the test equip users to make better decisions about their exercise routines and to order customized workout programs based on their genetic results.

"While all the genes in this kit have been studied in the past, these tests have not been widely available to the public primarily because of cost," said Bill Miller, CEO of AIBioTech.  "We have found an accurate and affordable way to make these tests available to athletes of all ages so they can maximize their potential while greatly reducing the risk of injury and even death."

With spring sports getting underway and summer athletics around the corner, the test is especially beneficial if applied to children.  As parents and kids embark on competitive sports, the results could shape decisions parents, coaches and trainers make about which sports are most appropriate for each specific child, the best methods of training and the potential for injury or life threatening conditions.  Miller referred to this as "…understanding the athlete from the inside out."  

AIBioTech developed the test after two years of analysis of genetic information gleaned from several Genetic research projects.  The company's goal was to create a simple diagnostic tool that parents and athletes could use to make informed decisions about participation in sports.  The recent sudden deaths of several gifted young athletes compelled the company's decision to bring the product to market at this time.

About AIBioTech

AIBioTech provides the next generation in DNA based genetic testing services bringing experience derived after performing almost 20 years of research and development services in the biotechnology field. AIBioTech is one of the world's most comprehensive Contract Research Organizations, and has developed customized solutions in the field of biologics and specialty diagnostics. AIBioTech's expertise in applied genetics, molecular biology, and human genomics has led the way into the next generation of sports science with the introduction of Sports X Factor.

AIBiotech operates under CLIA, or AABB accreditations for laboratory testing subject to regulatory oversight.


'/>"/>
SOURCE AIBioTech
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Nobel Winner Baruch Blumberg, Viral Genetics Advisor, Dies at 85
2. Reportlinker Adds Cytogenetics - Technologies, Markets and Companies
3. Ambry Genetics is First Authorized Customer Service Provider in New Ion Torrent CSP Program
4. Signal Genetics and Pronto Diagnostics Announce Distribution Agreement
5. Interleukin Genetics Reports Fourth Quarter and Year End 2010 Financial Results
6. First-of-Its-Kind Study Suggests Importance of Routine Mental Health Screening in the Care of Patients Suffering From Genetic Disease PKU
7. SG Biofuels Advances Jatropha Biotech Platform with Application of Genetic Markers to Reference Genome
8. Scientists from Toronto and Helsinki discover genetic abnormalities after creation of stem cells
9. WARFARIN Study Launched at WellStar Health System to Assess Impact of Genetic Testing in Reducing Hospitalizations and Deaths Caused by Warfarin
10. WARFARIN Study Launched at Overlake Hospital Medical Center to Assess Impact of Genetic Testing in Reducing Hospitalizations and Deaths Caused by Warfarin
11. Epeius Biotechnologies REXIN-G, a Tumor-Targeted Genetic Medicine for Metastatic Cancer, Gains Phase 3 Product Designation From the U.S. FDA
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/11/2017)... ... October 11, 2017 , ... The ... context, enabling overexpression experiments and avoiding the use of exogenous expression plasmids. The ... transformative for performing systematic gain-of-function studies. , This complement to loss-of-function studies, ...
(Date:10/11/2017)... 2017  VMS BioMarketing, a leading provider of patient support ... Nurse Educator (CNE) network, which will launch this week. The ... health care professionals to enhance the patient care experience by ... other health care professionals to help women who have been ... ...
(Date:10/11/2017)... (PRWEB) , ... October 11, 2017 , ... ... Administration (FDA) has granted orphan drug designation to SBT-100, its novel anti-STAT3 (Signal ... the treatment of osteosarcoma. SBT-100 is able to cross the cell membrane and ...
(Date:10/10/2017)... ... October 10, 2017 , ... Dr. Bob Harman, founder and ... San Diego Rotary Club. The event entitled “Stem Cells and Their ... 300+ attendees. Dr. Harman, DVM, MPVM was joined by two human doctors: Peter ...
Breaking Biology Technology:
(Date:4/5/2017)... , April 5, 2017  The Allen Institute for ... Cell Explorer: a one-of-a-kind portal and dynamic digital window ... imaging data, the first application of deep learning to ... stem cell lines and a growing suite of powerful ... for these and future publicly available resources created and ...
(Date:4/3/2017)... WASHINGTON , April 3, 2017 /PRNewswire-USNewswire/ ... single-cell precision engineering platform, detected a statistically ... cell product prior to treatment and objective ... highlight the potential to predict whether cancer ... prior to treatment, as well as to ...
(Date:3/29/2017)... 29, 2017  higi, the health IT company that ... North America , today announced a Series B ... of EveryMove. The new investment and acquisition accelerates higi,s ... to transform population health activities through the collection and ... higi collects and secures data today on behalf ...
Breaking Biology News(10 mins):